Absence of minimal residual disease (MRD) by reverse transcription polymerase chain reaction (RT-PCR) in CBF beta/MYH11-associated acute myeloid leukemia.

被引：0
作者：
Marcucci, G
Caligiuri, MA
Oberkircher, AR
Bloomfield, CD
机构：
[1] OHIO STATE UNIV,DIV HEMATOL ONCOL,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,ARTHUR G JAMES CANC HOSP,DIV HUMAN CANC GENET,COLUMBUS,OH 43210
[3] OHIO STATE UNIV,RES INST,COLUMBUS,OH 43210
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
[21]   Development of a Reverse Transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR) Assay for Nucleophosmin (NPM1) Minimal Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia [J].
Mai, M. ;
Viswanatha, D. S. ;
He, R. .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06) :932-932
[22]   Prognostic value of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) using polymerase chain reaction (PCR) [J].
Katsibardi, K. ;
Palathanasiou, C. ;
Moschovi, M. ;
Karamolegou, K. ;
Lambrou, G. I. ;
Tzortzatou-Stathopoulou, F. .
PEDIATRIC BLOOD & CANCER, 2007, 49 (03) :387-387
[23]   Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia [J].
G Marcucci ;
MA Caligiuri ;
H Döhner ;
KJ Archer ;
RF Schlenk ;
K Döhner ;
EA Maghraby ;
CD Bloomfield .
Leukemia, 2001, 15 :1072-1080
[24]   Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia [J].
Marcucci, G ;
Caligiuri, MA ;
Döhner, H ;
Archer, KJ ;
Schlenk, RF ;
Döhner, K ;
Maghraby, EA ;
Bloomfield, CD .
LEUKEMIA, 2001, 15 (07) :1072-1080
[25]   Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFb/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions. [J].
Laczika, K ;
Mitterbauer, G ;
Greinix, HT ;
Lechner, K ;
Jaeger, U .
BLOOD, 2000, 96 (11) :313A-313A
[26]   Development of a reverse transcription-polymerase chain reaction (RT-PCR) assay for the detection of Amasya cherry disease [J].
Kozlakidis, Z. ;
Citir, A. ;
Acikgoz, S. ;
Coutts, R. H. A. .
PLANT PATHOLOGY, 2007, 56 (06) :1032-1035
[27]   Real-time quantitative polymerase chain reaction (RQ-PCR) monitoring of minimal residual disease (MRD) in core binding factor acute myeloid leukaemia (CBF AML). [J].
Lane, Steven W. ;
Saal, Russell ;
Mollee, Peter ;
Grigg, Andrew ;
Taylor, Kerry ;
Seymour, John Francis ;
Kennedy, Glen ;
Williams, Bronwyn ;
Jones, Mark ;
Grimmett, Karen ;
Griffiths, Vanessa ;
Gill, Devinder ;
Hourigan, Matthew ;
Marlton, Paula .
BLOOD, 2006, 108 (11) :651A-651A
[28]   Detection of minimal residual disease using real-time RT-PCR in MLL/AF9 -: Positive acute myeloid leukemia. [J].
Scholl, C ;
Breitinger, H ;
Frohling, S ;
Schlenk, RF ;
Dohner, H ;
Dohner, K .
BLOOD, 2003, 102 (11) :376A-376A
[29]   Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement [J].
S Viehmann ;
A Teigler-Schlegel ;
J Bruch ;
C Langebrake ;
D Reinhardt ;
J Harbott .
Leukemia, 2003, 17 :1130-1136
[30]   Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement [J].
Viehmann, S ;
Teigler-Schlegel, A ;
Bruch, J ;
Langebrake, C ;
Reinhardt, D ;
Harbott, J .
LEUKEMIA, 2003, 17 (06) :1130-1136
12345